Study of Testicular Germ Cell Tumours with Monoclonal Antibodies
Author Information
Author(s): A.A. Epenetos, P. Travers, K.C. Gatter, R.D.T. Oliver, D.Y. Mason, W.F. Bodmer
Primary Institution: Imperial Cancer Research Fund
Hypothesis
Can monoclonal antibodies against placental alkaline phosphatase effectively identify testicular germ cell tumours?
Conclusion
The study found that the monoclonal antibody H17E2 strongly labels testicular germ cell tumours, while showing no reactivity with normal tissues.
Supporting Evidence
- All seminomas and malignant teratomas tested gave strong positive labelling with H17E2.
- Normal tissues showed no reactivity with the antibodies.
- Two cases of ovarian cancer and one case of endometrial cancer were positively stained by H17E2.
Takeaway
The researchers used special antibodies to find cancer cells in the testis, and they discovered that one of these antibodies works really well.
Methodology
Surgical biopsies were frozen, sectioned, and stained using immunoperoxidase techniques with monoclonal antibodies.
Limitations
The study may not account for all types of testicular tumours and their variations.
Want to read the original?
Access the complete publication on the publisher's website